1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Holly LaFon
Holly LaFon
Articles (6284) 

Invesco European Growth Fund Comments on MorphoSys

November 11, 2013 | About:

MorphoSys (XTER:MOR) is a German biotechnology company with a proprietary technology to develop human antibodies for specific diseases. The company signed two licensing deals (with GlaxoSmithKline PLC and Celgene Corp.) for its proprietary compounds, providing outside validation for its technology as well as upfront cash and future royalty payments.

From Invesco European Growth Fund’s third quarter 2013 commentary.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


GuruFocus Mobile App


User Generated Screeners


ssukumarGB-PL-BASIC2
trimbitamyPeterLynch
rael2222p ottimo
rael2222da finire assieme ad ottimo
rael2222BBB ottimo
rael2222Storici
rael2222AZAZAZAZ
rael2222AZAZAZ
xtianxing15897FastMover
rael2222azaz
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK